Hanlon Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-6,000
Closed -$1.15M – 129
2020
Q2
$1.15M Hold
6,000
– – 0.33% 48
2020
Q1
$930K Hold
6,000
– – 0.59% 35
2019
Q4
$502K Hold
6,000
– – 0.1% 75
2019
Q3
$406K Sell
6,000
-6,000
-50% -$395K 0.1% 62
2019
Q2
$797K Buy
12,000
+8,000
+200% +$466K 0.06% 68
2019
Q1
$222K Buy
+4,000
New +$244K 0.02% 112

Other funds holding TDOC

Hanlon Investment Management's TDOC Position: Q3 2020 in Review

Hanlon Investment Management sold out of Teladoc Health (TDOC) in Q3 2020, closing a stake of 6,000 shares — an estimated $1.15M sold.

Hanlon Investment Management first reported a position in TDOC in Q1 2019 and held it in 6 quarters. The position peaked at $1.15M in Q2 2020. 743 funds tracked by Wall St. Rank hold TDOC as of Q3 2020.

  • Hanlon Investment Management reported no remaining Teladoc Health position as of Q3 2020 after selling out during the quarter.
  • Hanlon Investment Management sold 6,000 Teladoc Health shares in Q3 2020, an estimated $1.15M.
  • Hanlon Investment Management first reported a position in Teladoc Health in Q1 2019 and held it in 6 quarters.
  • Hanlon Investment Management's Teladoc Health position peaked at $1.15M in Q2 2020.
  • 743 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2020.

Based on Hanlon Investment Management's 13F filing for Q3 2020, filed 17 Nov 2020.